Jose Fernando Moura, Oncologist and Principal Investigator in Solid Tumors at Real Hospital Portuguese and IMIP, shared a post by JAMA Oncology on X, adding:
“PROs are rising fast in clinical trials — and they’re proving to be powerful predictors OS. Is it time to rethink our reliance on PFS and give PROs the spotlight they deserve? The future of oncology may speak with the patient’s own voice.”
Quoting JAMA Oncology‘s post:
“Patient-reported outcomes, such as higher health status and lower symptom burden, are independently associated with improved overall survival in cancer patients.”
Title: Patient-Reported Outcomes as Prognostic Indicators for Overall Survival in CancerA Systematic Review and Meta-Analysis
Authors: Ryan S. Huang, David Chen, Ali Benour, Ryan Cortez, Andrew Mihalache, Carlton Johnny, Andrea Bezjak, Robert A. Olson, Srinivas Raman
More posts featuring Jose Fernando Moura on OncoDaily.